Date published: 2026-1-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

C3orf18 Inhibitors

Chemical inhibitors of C3orf18 function through various biochemical mechanisms to diminish the activity of this protein, which is implicated in cellular processes such as growth, proliferation, and stress responses. Rapamycin, a known mTORC1inhibitor, indirectly reduces C3orf18 activity by diminishing protein synthesis, crucial for cell growth that C3orf18 may facilitate. Similarly, LY 294002 and PD 98059 target the PI3K/AKT/mTOR and MAPK pathways, respectively, both essential for cell proliferation and survival, thus potentially reducing C3orf18 activity. WZB117 and 2-Deoxy-D-glucose interfere with cellular energy production by inhibiting GLUT1 and hexokinase, respectively, leading to a decrease in ATP and reduced energy-dependent processes in which C3orf18 might be involved. Bortezomib disrupts protein degradation pathways, which could lead to cell cycle arrest or apoptosis, thereby indirectly decreasing C3orf18 activity if it is related to cell viability. Further, SB 203580's inhibition of p38 MAPK and the DNA-damaging effect of Mitomycin C could lead to reduced stress response or cell cycle arrest, potentially diminishing C3orf18's role in these processes.

Additionally, Triptolide's broad-spectrum inhibition of transcription factors and U0126's targeting of MEK1/2 could lead to a reduction in cellular processes that may involve C3orf18. Geldanamycin's binding to Hsp90 disrupts the proper folding of proteins, which could destabilize C3orf18 if it is Hsp90-dependent. Lastly, Sulforaphane suppresses the NF-κB pathway, which is implicated in cell survival, thus potentially inhibiting C3orf18 activity if the protein operates within this pathway. These chemical inhibitors, through their targeted action on specific cellular pathways and processes, offer a diverse approach to indirectly reducing the functional activity of C3orf18 without directly targeting its transcription, translation, or general activation mechanisms, but rather by influencing the biochemical pathways that C3orf18 is potentially involved in.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Geldanamycin

30562-34-6sc-200617B
sc-200617C
sc-200617
sc-200617A
100 µg
500 µg
1 mg
5 mg
$39.00
$59.00
$104.00
$206.00
8
(1)

Geldanamycin binds to Hsp90, inhibiting its chaperone function. As Hsp90 is involved in the proper folding and stability of many proteins, its inhibition could lead to decreased activity of C3orf18, particularly if C3orf18 requires Hsp90 for its stability or function.

D,L-Sulforaphane

4478-93-7sc-207495A
sc-207495B
sc-207495C
sc-207495
sc-207495E
sc-207495D
5 mg
10 mg
25 mg
1 g
10 g
250 mg
$153.00
$292.00
$489.00
$1325.00
$8465.00
$933.00
22
(1)

Sulforaphane is a compound that inhibits the NF-κB pathway and induces phase II detoxification enzymes. By inhibiting NF-κB, which is involved in cell survival and proliferation, Sulforaphane could indirectly lead to the inhibition of C3orf18 activity if it is associated with this pathway.